NCT06523153View on ClinicalTrials.gov

A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
COVID-19
Interventions
BIOLOGICAL

VYD2311

Monoclonal antibody

OTHER

Placebo

Matching Placebo

Trial Locations (1)

Unknown

Invivyd Investigative Site, Joondalup

Sponsors

Lead Sponsor

Invivyd, Inc.
All Listed Sponsors
collaborator

Novotech (Australia) Pty Limited

INDUSTRY

lead

Invivyd, Inc.

INDUSTRY

NCT06523153 - A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants | Biotech Hunter | Biotech Hunter